References
- The 1984 report of the Joint National Committee on Detection. Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1984: 144(5): 1045–57
- Gifford RW Jr. Essential hypertension: cost-effective evaluation and treatment. Am J Med 1986: 81 (Suppl 6C): 33–8
- Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. 1. Results In patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 1967: 202(11): 1028–34
- Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. H Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 1970: 213(7): 1143–52
- National Heart Foundation of Australia. The Australian Therapeutic Trial in Mild Hypertension: report by the management committee. Lancet 1980: 1(8181): 1261–7
- Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. I. Reduction In mortality of persons with high blood pressure. Including mild hypertension. JAMA 1979: 242(23): 2562–71
- The effect of treatment on mortality in “mild” hypertension: results of the Hypertension Detection and Follow-up Program. N Engl J Med 1982: 307(16): 976–80
- Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. Br Med J (Clin Res) 1985: 291(6488): 97–104
- Amery A, Birkenhager W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet 1985: 1(8442): 1349–54
- Multiple Risk Factor Intervention Trial Research Group. Baseline rest electrocardiographic abnormalities, antihypertensive treatment and mortality in the Multiple Risk Factor Intervention Trial. Am J Cardiol 1985: 55(1): 1–15
- Grimm RH Jr. Thiazide diuretics and selective alpha blockers: comparison of use in antihypertensive therapy. Including possible differences In coronary heart disease risk reduction. Am J Med 1987: 82(Suppl 1 A): 26–30
- Weldmann P, Uehlinger DE, Gerber A. Antihypertensive treatment and serum lipoproteins. J Hypertens 1985: 3(4): 297–306
- Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction In Incidence of coronary heart disease. JAMA 1984: 251(3): 351–64
- Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results, n. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984: 251(3): 365–74
- Dzau VJ. Evolution of the clinical management of hypertension: emerglng role of “specific” vasodilators as Initial therapy. Am JMed 1987: 82(Suppl 1A): 36–43
- Croog SH, Levine S, Testa MA, et al. The effects of antihypertensive therapy on the quality of Ufe. N Engl JMed 1986: 314(26): 1657–64